Skip to main navigation menu Skip to main content Skip to site footer

Narrative Review

Vol. 10 No. 1 (2007)

Is There a Need for Neonatal Screening of Glucose-6-Phosphate Dehydrogenase Deficiency in Canada?

  • Aaron Leong
November 7, 2020




  1. Steensma DP, Hoyer JD, Fairbanks VF. Hereditary Red Blood Cell Disorders in Middle Eastern Patients. Tutorial: Mayo Clinic Proceedings. 2001 Mar; 76(3):285-93.
  2. Verle P, Nhan DH, Tinh TT, Uyen TT, Thuong ND, Kongs A, Stuyft P, Coosemans M. Glucose-6-phosphate Dehydrogenase Deficiency in Northern Vietnam. Tropical Medicine & International Health. 2000 Mar; 5(3):203-6.
  3. Boerkoel S, Yip YY: Mass Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency in Singapore. Southeast Asian Journal of Tropical Medicine & Public Health. 30 Suppl 1999; 2:70-1.
  4. Kaplan M, Hammerman C. Glucose-6-phosphate Dehydrogenase -deficient Neonates. A Potential Cause for Concern in North America. Pedriatrics. 2000 Dec; 16(6):1478-9.
  5. Joseph R, Ho LY, Gomez JM, Rajdurai VS, Sivasankaran S, Yip YY. Mass Newborn Screening for Glucose-6-phosphate Dehydrogenase Deficiency in Singapore. Southeast Asian Journal of Tropical Medicine & Public Health. 30 Suppl 1999; 2:70-1.
  6. Facts and Figures 2002: Immigration Overview. In Accessed on 20 November 2004
  7. Migot-Nabias F, Mombo LE, Luty AJ, Dubois B, Nabias R, Bisseye C, Millet P, Lu CY, Deloron P. Human Genetic Factors Related to Susceptibility to Mild Malaria in Gabon. Genes & Immunity. 2000 Oct; 7:435-41.
  8. Ahmed SG, Ibrahim UA: Clinical Significance of Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Patients with Sickle Cell Disease. Nigerian Postgraduate Medical Journal. 2002 Dec; 9(4):181-5.
  9. Aster JC. Red Blood Cell and Bleeding Disorders. In Kumar V, Abul K, Fausto N. Robbins and Contran Pathologic Basis of Disease, 7th ed, Philadelphia: Elsevier Saunders; 2005: 619-659.
  10. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T. Enhanced Erythrocyte Apoptosis in Sickle Cell Anemia, Thalassemia and Glucose-6-phosphate Dehydrogenase Deficiency. Cellular Physiology & Biochemistry 2002; 12(5-6):365-72.
  11. Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate Dehydrogenase Deficiency. Balliers Best Prac Res Clin Hematol 2000; 13:2.
  12. Quak SH, Saha N, Tay JS. Glucose-6-phosphate Dehydrogenase Deficiency in Singapore. Annals of the Academy of Medicine, Singapore. 1996 Jan; 25(1):45-8.
  13. Huang CS, Hung KL, Huang MJ, Li YC, Liu TH, Tang TK. Neonatal Jaundice and Molecular Mutations in Glucose-6-phosphate Dehydrogenase Deficient Newborn Infants. American Journal of Hematology 1996 Jan; 51(1):19-25.
  14. Gaetani GF, Rolfo M, Arena S, Mangerini R, Meloni GF, Ferraris AM. Active Involvement of Catalase during Hemolytic Crises of Favism. Blood Aug 1 1996; 88(3):1084-8.
  15. Au WY, Ma SK, Lie AK, Liang R, Cheng T, Kwong YL. Glucose-6-phosphate Dehydrogenase Deficiency and Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation 2002 Mar; 29(5):399-402.
  16. Gaskin RS, Estwick D, Peddi R. G6PD Deficiency: Its Role in the High Prevalence of Hypertension and Diabetes Mellitus. Ethnicity & Disease 2001 Fall; 11(4):749-54.
  17. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, Handy DE, Loscalzo J, Apstein CS, Liao R. Glucose-6-phosphate Dehydrogenase Modulates Cytosolic Redox Status and Contractile Phenotype in Adult Cardiomyocytes. Circulation Research 2003 Jul 25;
  18. (2):9-16.
  19. Liese AM, Siddiqi MQ, Siegel JH, Deitch EA, Spolarics Z. Attenuated Monocyte IL-10 Production in Glucose-6-phosphate Dehydrogenase-deficient Trauma Patients. Shock 2002 Jul; 18(1):18-23.
  20. Tabbara KF, Sharara NA, Al-Momen AK. Toxoplasmosis in a Group of Glucose-6-phosphate Dehydrogenase Deficient patients. Saudi Medical Journal 2001 Apr; 22(4):330-2.
  21. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chiu DT. Impaired Production of Nitric Oxide, Superoxide, and Hydrogen Peroxide in Glucose 6-phosphate-dehydrogenase-deficient Granulocytes. FEBS Letters 1998 Oct 9; 436(3):411-4.
  22. Ali NA, al-Naama LM, Khalid LO. Haemolytic Potential of Three Chemotherapeutic Agents and Aspirin in Glucose-6-phosphate Dehydrogenase Deficiency. Eastern Mediterranean Health Journal 1999 May; 5(3):457-64.
  23. Meloni G, Meloni T: Glyburide-induced Acute Hemolysis in a G6PD-deficient Patient with NIDDM. British Journal of Haematology 1996 Jan; 92(1):159-60.
  24. Liao YP, Hung DZ, Yang DY. Hemolytic Anemia after Methylene Blue Therapy for Aniline-induced Methemoglobinemia. Veterinary & Human Toxicology 2002 Feb; 44(1):19-21.
  25. Gauthier TW: Methylene Blue-induced Hyperbilirubinemia in Neonatal Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency. Journal of Maternal-Fetal Medicine 2000 Jul-Aug; 9(4):252-4.
  26. Santucci K, Shah B. Association of Naphthalene with Acute Hemolytic Anemia. Academic Emergency Medicine 2000 Jan; 7(1):42-7.
  27. Kok AN, Ertekin MV, Ertekin V, Avci B. Henna (Lawsonia inermis Linn.) Induced Hemolytic Anemia in Siblings. International Journal of Clinical Practice 2004 May; 58(5):530-2.
  28. Kandil HH, al-Ghanem MM, Sarwat MA, al-Thallab FS. Henna (Lawsonia inermis Linn.) Inducing Hemolysis among G6PD-deficient Newborns. A New Clinical Observation. Annals of Tropical Paediatrics 1996 Dec; 16(4):287-91.
  29. Zinkham WH, Oski FA: Henna: a Potential Cause of Oxidative Hemolysis and Neonatal Hyperbilirubinemia. Pediatrics. 1996 May; 97(5):707-9.
  30. Nussbaum RL, McInnes RR, Willard HF Thompson and Thompson Genetics in Medicine, 6th ed, Philadelphia: WB Saunders Company;391-398
  31. Lim HH, Daniel LM, Lee J, Tan MC. Predicting Significant Hyperbilirubinaemia and Early Discharge for Glucose-6-phosphate Dehydrogenase Deficient Newborns. Annals of the Academy of Medicine, Singapore 2003 Mar; 32(2):257-61.


Download data is not yet available.